Search

While medication adherence is a cornerstone of value-based care, it depends on the right team, tools and targeted patient engagement to be effective, says one chief medical officer.

The Drug Enforcement Administration is excusing Veterans Affairs' virtual care providers from participating in a federal telehealth controlled substance registry framework if the patient had a previous in-person visit.

The rule would establish a framework for a telehealth controlled substance registry and authorize three types of special registration. Some industry groups have voiced concerns for providers in their initial reactions to the proposed rule.

The CEO of Wolters Kluwer Health sees big artificial intelligence developments this year – and predicts that AI is moving from a reactive force in healthcare to a proactive one.

As one telemedicine CEO looks to the year ahead, he predicts RPM will improve outcomes for congestive heart failure patients and help manage those on the wildly popular GLP-1 diabetes and weight loss medications.

A health analytics company is partnering with pharma to allow patients to unify their health information across multiple providers. By leveraging artificial intelligence, the DTP platform analyzes medical records and makes recommendations. 

Health IT companies join providers and healthcare industry groups in asking the top Congressional leaders to extend the telehealth flexibilities as the EOY 2024 deadline looms.

The University of Oklahoma College of Medicine did a controlled test and showed the odds of infection-related readmissions were decreased in the RTM group by 76% at 30 days, 80% at 60 days and 68% at 90 days.

A pilot validation study found that the AI helped hasten case reviews and data analysis and determine the necessity of antibiotic use.

The third extension of pandemic-era telehealth flexibilities through the end of next year will give the agencies time to promulgate final regulations and providers time to comply, the agencies said.